Delivery Order SPE2DB22D2206-SPE2DB25FGL81

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,360.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,186,094 units of Diprivan 1,000 mg/100 ml vials, a critical anesthetic medication. This delivery order is part of AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,683.26 firm fixed price contract is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a pharmaceutical product. The award has an ultimate completion date of July 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,340.24 firm fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a pharmaceutical product, with an ultimate completion date of February 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,449.44 firm fixed-price delivery order is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific award is for...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a for-profit pharmaceutical distribution company, for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $2,469.73 and an ultimate completion date of April 23, 2024. It is a delivery order contract with a firm fixed-price pricing type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,173.47 for the product "DIPRIVAN 200 MG/20 ML VIAL 20ML". The award has an ultimate completion date of February 27, 2025 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,828.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical medical product, with an ultimate completion date of November 8, 2024. This award is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $1,030.00 fixed-price delivery order is for the supply of 1,000 mg/100 mL vials of the anesthetic drug Diprivan. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,301.25 firm fixed-price delivery order contract is for the supply of 1,000 mg/100 ml vials of the drug Diprivan. The contract has an ultimate completion date of February 25, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGL81
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract, valued at $3,762.40, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product, to support military healthcare programs. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive federal contracting history and expertise in providing a comprehensive range of pharmaceutical products and medical supplies to various government agencies, including the DLA and Department of Justice, make them a key vendor for critical federal healthcare needs.

Generated 7/8/25, 2:25 PM